Krusić J, Kirhmajer V, Knezević M, Ikić D, Maricić Z, Rode B, Jusić D, Soos E
J Cancer Res Clin Oncol. 1981;101(3):309-15. doi: 10.1007/BF00410116.
Fifteen patients with invasive squamous cell carcinoma of the uterine cervix were treated with human leukocyte interferon (HLI). HLI was applied topically and i.m. to nine patients, and only topically to six. After therapy, surgical material was free from tumor cells in three patients, tumor cells were identified as invasive carcinoma in one patient and as CA in situ in two patients. Findings remained unchanged in nine patients. Tumor metastases in the lymph nodes were found in only one patient. The patients' overall response to therapy was assessed on the basis of stromal response, relation of tumor cells and macrophage activity, and the reactivity of lymph nodes.
15例子宫颈浸润性鳞状细胞癌患者接受了人白细胞干扰素(HLI)治疗。9例患者采用局部和肌肉注射HLI,6例仅采用局部用药。治疗后,3例患者的手术标本中无肿瘤细胞,1例患者的肿瘤细胞被鉴定为浸润癌,2例为原位癌。9例患者的病情无变化。仅1例患者发现有淋巴结转移。根据间质反应、肿瘤细胞与巨噬细胞活性的关系以及淋巴结的反应性对患者的总体治疗反应进行评估。